Affiliation:
1. Pamukkale Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Denizli, Türkiye
2. HİTİT ÜNİVERSİTESİ, TIP FAKÜLTESİ
Abstract
Purpose: To investigate the frequency of MBLs in Pseudomonas and Acinetobacter species with E-test, to determine the risk factors and to evaluate the demographic and clinical features of infected patients. Materials and methods: Imipenem or meropenem resistance of Pseudomonas and Acinetobacter isolated from several clinical samples with conventional methods were evaluated with imipenem EDTA E-test and the presence of Metallo-β-lactameses MBL was examined. Several isolates were screened for VIM-1, VIM-2, IMP-1, and IMP-2 with a PCR test. Results: Of 46 carbapenem resistant Acinetobacter isolates, 41 (89%), as well as of 19 carbapenem resistant Pseudomonas isolates, 5 (26%) had MBL positivity with imipenem-EDTA E-test. A history of Intensive Care Unit stay, mechanical ventilation and cephalosporin use were found to be significant risk factors with respect to MBL production. Conclusion: Detection of MBL production in Acinetobacter and Pseudomonas species especially in ICU patients is of prime importance to control infection rapidly and effectively, which contribute to prevention of outbreaks.
Reference35 articles.
1. Resources
1. Chhatwal P, Ebadi E, Schwab F, et al. Epidemiology and infection control of carbapenem resistant Acinetobacter baumannii and Klebsiella pneumoniae at a German university hospital: a retrospective study of 5 years (2015-2019). BMC Infect Dis. 2021 Nov 27;21(1):1196. doi: 10.1186/s12879-021-06900-3 PMID: 34837973; PMCID: PMC8627082.
2. 2. Zarrilli R, Bagattini M, Migliaccio A, Esposito EP, Triassi M. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Italy. Ann Ig. 2021 Sep-Oct;33(5):401-409. doi: 10.7416/ai.2020.2395 Epub 2020 Dec 4. PMID: 33270079.
3. 3. Ling, W., Furuya-Kanamori, L., Ezure, Y., Harris, P., & Paterson, D. L. (2021). Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysis. JAC-antimicrobial resistance, 3(4), dlab157. https://doi.org/10.1093/jacamr/dlab157
4. 4. David L. Paterson. The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species, Clinical Infectious Diseases, Volume 43, Issue Supplement_2, September 2006, Pages S43–S48, https://doi.org/10.1086/504476
5. 5. Ferreira, K. M. Rodrigues, A. C. D. S., Watanabe, A. C., Ferreira, Y. M., & Chang, M. R. (2017). First case of infection by metallo-β-lactamase-producing Pseudomonas aeruginosa in Mato Grosso do Sul, Brazil. Brazilian Journal of Infectious Diseases, 21, 359-360. http://dx.doi.org/10.1016/j.bjid.2016.12.005